Willow House 820 Residential offers Substance Use Treatment, Co-occurring (Substance + Mental Health). Contact us or call our helpline for a detailed breakdown of available programs and current availability.

Yes, Willow House 820 Residential accepts Medicaid. For qualifying residents in NY, most or all treatment costs may be covered at no out-of-pocket expense.

Yes, Willow House 820 Residential provides medication-assisted treatment (MAT). MAT combines FDA-approved medications such as buprenorphine or naltrexone with counseling to treat alcohol and opioid use disorders.

Yes, Willow House 820 Residential offers dual diagnosis treatment for individuals with co-occurring substance use and mental health disorders such as depression, anxiety, PTSD, and bipolar disorder.

Yes, Willow House 820 Residential provides gender-specific treatment programs for women. These programs are designed to address the unique challenges women face in recovery, including trauma, family dynamics, and co-occurring disorders.

Yes, Willow House 820 Residential offers treatment programs for adolescents and young adults. Youth-specific programs address developmental needs and often include family therapy components.

Yes, Willow House 820 Residential offers residential treatment where patients live at the facility for 30–90+ days. Residential care provides 24/7 support and is typically recommended for those with severe dependence or who need a structured environment.

Willow House 820 Residential is listed in the SAMHSA National Directory of Mental Health Treatment Facilities. Call our helpline to confirm current accreditation status.

Call our free helpline at 1-888-767-3708 to speak with an admissions advisor. They can verify your insurance, explain program options, and help you take the first step toward recovery — 24/7, at no cost.